Mark DeLong - Jan 29, 2024 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Business & Strat Officer
Signature
/s/ David Watson, attorney-in-fact for Mark DeLong
Stock symbol
APLS
Transactions as of
Jan 29, 2024
Transactions value $
-$23,539
Form type
4
Date filed
1/31/2024, 04:18 PM
Previous filing
Jan 23, 2024
Next filing
Feb 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale -$23.5K -367 -0.56% $64.14 65.2K Jan 29, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares sold to cover tax withholding on the Restricted Stock Units released on 01/26/2024.